Audio

Fred Lublin, MD

Publish date: June 24, 2014

Dr. Fred Lublin describes the US National Multiple Sclerosis Society's recent revisions to the clinical subtypes of multiple sclerosis.


 

Recommended Reading

MS experts battle over alemtuzumab’s value
MDedge Neurology
Aquatic therapy deemed beneficial for MS patients
MDedge Neurology
When switching from natalizumab to teriflunomide, timing is key
MDedge Neurology
Copaxone lipoatrophy far more common than reported
MDedge Neurology
Prospective studies needed to compare MS in African Americans and whites
MDedge Neurology
Deborah Backus, PhD
MDedge Neurology
Gary Cutter, PhD
MDedge Neurology
Frederick Foley, PhD
MDedge Neurology
VIDEO: Helping MS patients regain use of their limbs
MDedge Neurology
Changing marijuana laws pose health challenges
MDedge Neurology